Condition
Herbal Interaction
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 3 (1)
Trial Status
Completed2
Enrolling By Invitation1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05846451Early Phase 1RecruitingPrimary
Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints
NCT05739071Not ApplicableEnrolling By Invitation
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
NCT05504447Not ApplicableUnknownPrimary
To Evaluate the Efficacy and Safety of "Rongyang Zhengyifang" Tea Bag With COVID-19 Variant Virus
NCT04702659CompletedPrimary
Chinese Medicine Zhengyi Prescription Tea Bag
NCT04974073Phase 3Completed
Development of PHY606 as Adjunct Therapy for Anemia Patients
Showing all 5 trials